TY - JOUR T1 - Lowering blood pressure after acute intracerebral haemorrhage: protocol for a systematic review and meta-analysis using individual patient data from randomised controlled trials participating in the Blood Pressure in Acute Stroke Collaboration (BASC) JF - BMJ Open JO - BMJ Open DO - 10.1136/bmjopen-2019-030121 VL - 9 IS - 7 SP - e030121 AU - Tom J Moullaali AU - Xia Wang AU - Lisa J Woodhouse AU - Zhe Kang Law AU - Candice Delcourt AU - Nikola Sprigg AU - Kailash Krishnan AU - Thompson G Robinson AU - Joanna M Wardlaw AU - Rustam Al-Shahi Salman AU - Eivind Berge AU - Else C Sandset AU - Craig S Anderson AU - Philip M Bath A2 - , Y1 - 2019/07/01 UR - http://bmjopen.bmj.com/content/9/7/e030121.abstract N2 - Introduction Conflicting results from multiple randomised trials indicate that the methods and effects of blood pressure (BP) reduction after acute intracerebral haemorrhage (ICH) are complex. The Blood pressure in Acute Stroke Collaboration is an international collaboration, which aims to determine the optimal management of BP after acute stroke including ICH.Methods and analysis A systematic review will be undertaken according to the Preferred Reporting Items for Systematic review and Meta-Analysis of Individual Participant Data (IPD) guideline. A search of Cochrane Central Register of Controlled Trials, EMBASE and MEDLINE from inception will be conducted to identify randomised controlled trials of BP management in adults with acute spontaneous (non-traumatic) ICH enrolled within the first 7 days of symptom onset. Authors of studies that meet the inclusion criteria will be invited to share their IPD. The primary outcome will be functional outcome according to the modified Rankin Scale. Safety outcomes will be early neurological deterioration, symptomatic hypotension and serious adverse events. Secondary outcomes will include death and neuroradiological and haemodynamic variables. Meta-analyses of pooled IPD using the intention-to-treat dataset of included trials, including subgroup analyses to assess modification of the effects of BP lowering by time to treatment, treatment strategy and patient’s demographic, clinical and prestroke neuroradiological characteristics.Ethics and dissemination No new patient data will be collected nor is there any deviation from the original purposes of each study where ethical approvals were granted; therefore, further ethical approval is not required. Results will be reported in international peer-reviewed journals.PROSPERO registration number CRD42019141136. ER -